Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MicroRNA 6836 is a small, non-coding RNA gene in humans whose mature product functions by regulating gene expression at the post-transcriptional level[5]. It can be detected in serum and is one member of a seven-miRNA signature used in composite indices for the diagnosis of bone and soft tissue sarcomas[1]. However, current evidence indicates that MIR6836 is not used individually for disease classification or as a stand-alone drug target, nor are there known drugs targeting this specific microRNA.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MicroRNA 6836 (MIR6836).